BRIEF-Psyence Biomed Announces Strategic Ibogaine Investment
Reuters2026/09/23 11:04Psyence Biomedical Ltd PBM.O:
PSYENCE BIOMED ANNOUNCES STRATEGIC IBOGAINE INVESTMENT
PSYENCE BIOMEDICAL -AGREES TO INVEST UP TO $5 MILLION IN PSYLABS, $2.40 MILLION COMMITTED
PSYENCE BIOMEDICAL - CO AND PSYLABS AGREE TO $9 MILLION VALUE-MATCHED SHARE EXCHANGE
PSYENCE BIOMEDICAL - POST-DEAL, PSYLABS TO HOLD 49.89% OF PSYENCE BIOMED, PSYENCE BIOMED 41.13% OF PSYLABS
Source text: ID:nGNX8m9Ck4
Further company coverage: PBM.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gram Is Only Bright Spot in Crypto Bloodbath, Durov Says
AI trading rebounds; storage chip and optical communication stocks rise broadly in U.S. pre-market, CoreWeave surges 17%, oil prices stabilize.
Before the US stock market opened, CoreWeave rose about 17% as its Q3 revenue exceeded expectations and the company raised its annual revenue guidance. Storage chip stocks generally increased, with SK Hynix up about 7% and SanDisk up about 7%. Optical communication stocks also rose, with Coherent up about 9%, Credo up about 8%, and Lumentum up about 8%. Futures for all three major US stock indexes were up: Nasdaq 100 index futures rose 1.6%, S&P 500 index futures rose 0.7%, and Dow Jones index futures rose 0.2%.
Fed repricing lifts US Dollar Index – Deutsche Bank
Crypto prices
More
